Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 3:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–9 of 9 matching trials from the live ClinicalTrials.gov search.

Conditions: End Stage Renal Disease
Interventions: Expedial Vascular Access Graft; Device
Lead sponsor: LeMaitre Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 8
States / cities: Miami, Florida • Baton Rouge, Louisiana • The Bronx, New York + 4 more

Conditions: Peripheral Vascular Diseases
Interventions: Vascular graft; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 18
States / cities: Washington D.C., District of Columbia • Hollywood, Florida • Jacksonville, Florida + 14 more

Conditions: Herniorrhaphy, Humans, Polypropylene, Polytetrafluoroethylene, Histology, Materials Testing
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hyperplasia, Chronic Renal Failure
Interventions: edifoligide (E2F Decoy); Drug
Lead sponsor: Anesiva, Inc.; Industry
Eligibility: 18 Years to 79 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 21
States / cities: Los Angeles, California • Hudson, Florida • Miami, Florida + 15 more

Conditions: Vascular Surgical Bleeding
Interventions: Fibrin Sealant Grifols, Manual Compression; Biological · Procedure
Lead sponsor: Instituto Grifols, S.A.; Industry
Eligibility: Not listed
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 27
States / cities: Florence, Alabama • Palo Alto, California • San Diego, California + 23 more

Conditions: End Stage Renal Disease, Hemolysis, Arteriovenous Graft
Interventions: Expanded polytetrafluoroethylene Graft, Bovine Carotid Artery Graft; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses
Interventions: Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr), Surgical gauze pads; Biological · Other
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: Not listed
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 22
States / cities: Birmingham, Alabama • Tucson, Arizona • Fresno, California + 19 more

Conditions: Alveolar Ridge Preservation, Tooth Extraction
Interventions: Leukocyte platelet rich fibrin plug + d-PTFE membrane, d-PTFE membrane; Biological · Device
Lead sponsor: Firas Al Yafi; Other
Eligibility: 18 Years to 80 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.